CRANE STRATEGIES

Lobbying for REGENERON PHARMACEUTICALS, INC. · Biopharmaceutical development and manufacturing

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New York · House · Senate · $50,000.00 income · posted Oct 1, 2025

Lobbying activity 1

Budget/Appropriations

Biodefense funding

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem